Goldman Sachs’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $16.1K | Sell |
|
|||||
|
2022
Q4 | $11.7K | Sell |
|
|||||
|
2022
Q3 | $72K | Sell |
|
|||||
|
2022
Q2 | $242K | Sell |
|
|||||
|
2022
Q1 | $466K | Sell |
|
|||||
|
2021
Q4 | $1.6M | Buy |
|
|||||
|
2021
Q3 | $680K | Sell |
|
|||||
|
2021
Q2 | $5.25M | Sell |
|
|||||
|
2021
Q1 | $8.41M | Buy |
|
|||||
|
2020
Q4 | $7.67M | Buy |
|
|||||
|
2020
Q3 | $962K | Buy |
|
|||||
|
2020
Q2 | $256K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $984K | Buy |
|